<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cell Therapy Archives - Biotherapy Partners</title>
	<atom:link href="https://biotherapypartners.com/tag/cell-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://biotherapypartners.com/tag/cell-therapy/</link>
	<description>Commited to your success</description>
	<lastBuildDate>Tue, 25 Jul 2023 17:26:51 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.5.2</generator>

<image>
	<url>https://biotherapypartners.com/wp-content/uploads/2022/12/cropped-logo_site_mini-32x32.png</url>
	<title>Cell Therapy Archives - Biotherapy Partners</title>
	<link>https://biotherapypartners.com/tag/cell-therapy/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Support for the preparation of an IND package</title>
		<link>https://biotherapypartners.com/support-for-the-preparation-of-an-ind-package/</link>
		
		<dc:creator><![CDATA[bncsys]]></dc:creator>
		<pubDate>Wed, 07 Jun 2023 15:15:23 +0000</pubDate>
				<category><![CDATA[Regulatory and operational support]]></category>
		<category><![CDATA[Cell Therapy]]></category>
		<guid isPermaLink="false">https://biotherapypartners.fr/?p=1545</guid>

					<description><![CDATA[The request A biotech startup requested a support to review, supplement and complete the necessary ... <a title="Support for the preparation of an IND package" class="read-more" href="https://biotherapypartners.com/support-for-the-preparation-of-an-ind-package/" aria-label="More on Support for the preparation of an IND package">Read more</a>]]></description>
										<content:encoded><![CDATA[
<h3 class="gb-headline gb-headline-16269d35 gb-headline-text">The request</h3>



<p>A biotech startup requested a support to review, supplement and complete the necessary documentation for a <strong>clinical trial application</strong></p>



<h3 class="gb-headline gb-headline-18814ee4 gb-headline-text">Biotherapy Partners approach</h3>



<p>A review of the existing documentation was acomplished, a gap analysis was done, additional studies were performed if necessary, reports were written, the dossier for clininical trial application was prepared filed to regulatory agency, questions from the agency were answered and the clinical trial was initiated.</p>



<h3 class="gb-headline gb-headline-4fb76de8 gb-headline-text">Results</h3>



<p>BP identified the gaps, proposed supplementary studies and contributed to finalize a successful clinicical trial application for FDA.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Due diligence for cell therapy</title>
		<link>https://biotherapypartners.com/due-diligence-for-cell-therapy/</link>
		
		<dc:creator><![CDATA[bncsys]]></dc:creator>
		<pubDate>Mon, 15 May 2023 17:52:13 +0000</pubDate>
				<category><![CDATA[Due Diligence]]></category>
		<category><![CDATA[Cell Therapy]]></category>
		<guid isPermaLink="false">https://biotherapypartners.fr/?p=1357</guid>

					<description><![CDATA[The request Client was looking to complement its internal team with seasoned experts in cell ... <a title="Due diligence for cell therapy" class="read-more" href="https://biotherapypartners.com/due-diligence-for-cell-therapy/" aria-label="More on Due diligence for cell therapy">Read more</a>]]></description>
										<content:encoded><![CDATA[
<h3 class="gb-headline gb-headline-16269d35 gb-headline-text">The request</h3>



<p>Client was looking to <strong>complement its internal team</strong> with seasoned experts in cell therapy.</p>



<h3 class="gb-headline gb-headline-18814ee4 gb-headline-text">Biotherapy Partners approach</h3>



<p>BP reviewed existing data, focussing on critical, potentially deal-breaking data and interacts with third-party SMEs.</p>



<h3 class="gb-headline gb-headline-4fb76de8 gb-headline-text">Results</h3>



<p>BP pintpointed during due diligence key success factors for the deal &amp; next steps.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
